人工细胞毒性T淋巴细胞选择性地消除瘤细胞,以有效治疗癌症
Weijia Xu1, Mingda Yang1,2, Jihong Wang1
1School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, Guangdong 511442, P. R. China.
Nano letters
|June 10, 2025
概括
研究人员开发了一种人工细胞毒性T淋巴细胞 (aCTL) 纳米药物,可以选择性地向并摧毁癌细胞. 这种创新方法在临床前模型中通过抑制瘤生长,显示出有效的癌症治疗的前景.
科学领域:
- 生物医学工程 生物医学工程
- 纳米医学是一种纳米医学.
- 免疫治疗是一种免疫疗法.
背景情况:
- 细胞毒性T淋巴细胞 (CTLs) 在消除瘤细胞方面表现出高选择性,为癌症治疗激发了人工对应物.
- 目前的癌症疗法往往缺乏特异性,导致非目标效果和有效性有限.
- 纳米医学为开发向治疗剂提供了一个平台.
研究的目的:
- 设计一种能够选择性地识别和破坏癌细胞的人工CTL (aCTL).
- 将CTL功能的关键组件集成到一个超分子纳米结构中.
- 在各种癌症模型中评估aCTL的治疗疗效.
主要方法:
- 膜标结合部分,膜穿孔和治疗前药物的超分子组合成一个aCTL.
- 在体外评估aCTL结合特异性和膜穿孔能力.
- 在体内评估aCTL在抑制HepG2肝细胞癌,B16-F10黑色素瘤和患者衍生异种移植 (PDX) 乳腺癌模型中的瘤生长效果.
主要成果:
- aCTL证明了对癌细胞的选择性结合.
- aCTL成功地穿透了癌细胞膜,促进了前药物进入.
- 在HepG2,B16-F10和PDX乳腺癌模型中观察到显著的瘤生长抑制.
- 结合前药物被有效地切割并通过瘤细胞内的过度表达的膜转酶释放.
结论:
- 开发的aCTL代表了针对癌症向治疗的新型纳米医学平台.
- aCTL具有选择性向,穿孔和传递治疗药物的能力,为克服当前癌症治疗局限性提供了一个有前途的战略.
- 这种人造免疫细胞模仿显示出广泛应用在治疗各种固体瘤的显著潜力.
更多相关视频
09:28Quantitative High-throughput Single-cell Cytotoxicity Assay For T Cells
Published on: February 2, 2013
15.2K
09:57Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells
Published on: January 29, 2019
22.8K
相关概念视频
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Cytotoxic T Cells-mediated Immune Response
2.6K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
2.6K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
